Hormone-Biological Therapy in Breast Cancer: Preclinical Evidence,Clinical Studies and Future Directions

E-ISSN： 1873-5576|10|1|3-18

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.1, 2010-02, pp. : 3-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

Editorial [Hot Topic:Active and Passive A#946;-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part I (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 1, 2009-03 ,pp. : 1-6

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Active and Passive A#946;-Immunotherapy: Preclinical and Clinical Studies and Future Directions: Part II (Guest Editors: Michael G. Agadjanyan and David H. Cribbs)]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 2, 2009-04 ,pp. : 82-87

Bentham Science Publishers

Access to resources Recommend Favorite

The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy

By Justenhoven Christina Obazee Ofure Brauch Hiltrud

Pharmacogenomics, Vol. 13, Iss. 6, 2012-04 ,pp. : 659-675

Future Medicine

Access to resources Recommend Favorite